Stockreport

Largest Published Study of Molecular Residual Disease (MRD) in Stage III Colon Cancer Shows Guardant Reveal Blood Test More Precisely Identifies Risk of Recurrence After Surgery to Support...

Guardant Health, Inc.  (GH) 
Last guardant health, inc. earnings: 2/24 04:03 pm Check Earnings Report
PDF PALO ALTO, Calif. & ROCHESTER, Minn., February 02, 2026 BUSINESS WIRE )--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company and research collabora [Read more]